GASTROINTESTINAL STROMAL TUMORS

This study is testing if a simple blood test can help doctors choose the right drug for patients with advanced gastrointestinal tumors (GIST) that have stopped responding to standard treatment. Researchers will use the blood test to look for specific genetic changes in the cancer…

This study is testing if closely monitoring the level of the cancer drug imatinib in a patient's blood can help reduce severe side effects while still keeping their gastrointestinal stromal tumor (GIST) under control. Researchers will track 28 adults with GIST who are starting im…

This early-stage study aims to find a safe dose of fampridine (a multiple sclerosis drug) when combined with the cancer drug imatinib (Gleevec) for patients with a specific type of gastrointestinal stromal tumor (GIST). Researchers want to see if this two-drug combination is more…

This early-stage trial is testing a new cancer drug called NN3201 for the first time in people. The study aims to find a safe dose and see how well the drug works against several advanced solid tumors that have a specific protein called c-Kit. Researchers will enroll 67 adults wi…

This study is testing if follow-up care for certain rare cancers can be done just as well remotely by a nurse over the phone, compared to traditional in-person visits with a doctor at the hospital. It aims to see if patients stick to their recommended check-up schedule better wit…

This study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…